(RTTNews) - VivoSim Labs, Inc. (VIVS) and Chemveda Life Sciences have entered into a strategic collaboration to evaluate AI-designed drug compounds using VivoSim's human-relevant 3D tissue models, aiming to identify potential safety and efficacy issues earlier in drug development